We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVCO
3251
Silvaco Group
SVCO
$256M
| $81.2K | ﹤0.01% |
+5,682
| New | +$93.9K |
|
3252
Ovid Therapeutics
OVID
$491M
| $81.1K | ﹤0.01% |
68,723
-1,010
| -1% | -$1.05K |
|
3253
ENI
E
$77.5B
| $80.6K | ﹤0.01% |
2,659
| – | – |
|
|
ALAR
3254
Alarum Technologies
ALAR
$14.3M
| $80.2K | ﹤0.01% |
7,540
+2,056
| +37% | +$44.2K |
|
3255
Stem
STEM
$52.7M
| $79.8K | ﹤0.01% |
11,474
-1,646
| -13% | -$25.9K |
|
3256
AirSculpt Technologies
AIRS
$353M
| $79.6K | ﹤0.01% |
15,693
-1,183
| -7% | -$5.14K |
|
3257
iShares MSCI Italy ETF
EWI
$1.07B
| $79.1K | ﹤0.01% |
2,030
-4,150
| -67% | -$156K |
|
3258
Scilex Holding
SCLX
$48.9M
| $78.5K | ﹤0.01% |
2,424
+18
| +0.7% | +$862 |
|
|
CO
3259
DELISTED
Global Cord Blood Corporation
CO
| $78.3K | ﹤0.01% |
44,757
| – | – |
|
3260
INmune Bio
INMB
$57.9M
| $77.2K | ﹤0.01% |
14,320
+547
| +4% | +$3.89K |
|
3261
ALX Oncology
ALXO
$290M
| $76.6K | ﹤0.01% |
42,111
-13,109
| -24% | -$48.7K |
|
|
RDNW
3262
RideNow Group
RDNW
$262M
| $76K | ﹤0.01% |
15,863
-3,909
| -20% | -$16.1K |
|
|
QXO
3263
QXO Inc
QXO
$17.4B
| $75.7K | ﹤0.01% |
+4,800
| New | +$140K |
|
3264
BlackSky Technology
BKSY
$1.19B
| $75.1K | ﹤0.01% |
15,839
-2,009
| -11% | -$15.9K |
|
3265
D-Wave Quantum Inc. Common Stock
QBTS
$7.73B
| $74.7K | ﹤0.01% |
75,967
-5,185
| -6% | -$5.19K |
|
3266
OppFi
OPFI
$803M
| $74.4K | ﹤0.01% |
15,728
+1,843
| +13% | +$7.65K |
|
|
HHR
3267
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $74.1K | ﹤0.01% |
4,932
| – | – |
|
3268
Northern Technologies International Corp
NTIC
$80M
| $74K | ﹤0.01% |
6,023
-868
| -13% | -$11.5K |
|
3269
Actinium Pharmaceuticals
ATNM
$25M
| $73.3K | ﹤0.01% |
38,996
-660
| -2% | -$2.61K |
|
3270
Cibus
CBUS
$138M
| $73.2K | ﹤0.01% |
22,468
+41
| +0.2% | +$297 |
|
3271
Klaviyo
KVYO
$4.73B
| $72.6K | ﹤0.01% |
+2,051
| New | +$59.4K |
|
|
CANG
3272
Cango Inc
CANG
$68.5M
| $72.2K | ﹤0.01% |
4,056
| – | – |
|
|
DRD
3273
DRDGold
DRD
$2.05B
| $71.6K | ﹤0.01% |
7,431
| – | – |
|
3274
Nerdy
NRDY
$96.7M
| $70.5K | ﹤0.01% |
71,744
-12,995
| -15% | -$16.6K |
|
3275
Outlook Therapeutics
OTLK
$191M
| $70.2K | ﹤0.01% |
13,154
+2,563
| +24% | +$18.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.